Review of the stability of photosensitive medications

I Sánchez-Quiles, MD Nájera-Pérez… - Farmacia Hospitalaria …, 2011 - Elsevier
Objectives Identify the photosensitive drugs included in the hospital pharmacotherapeutic
guide and search for stability data on the storage, reconstitution, and dilution of these …

Isavuconazole–tacrolimus drug–drug interactions in HSCT patients

L Fructuoso-González, MD Najera-Perez… - Journal of …, 2023 - academic.oup.com
Objectives Because tacrolimus has a narrow therapeutic window and exhibits both
intraindividual and interindividual variability, we attempted to establish the percentage of …

[HTML][HTML] Revisión de la estabilidad de los medicamentos fotosensibles

I Sánchez-Quiles, MD Nájera-Pérez, A Espuny-Miró… - Farmacia …, 2011 - Elsevier
Objetivo Identificar los medicamentos fotosensibles incluidos en la guía farmacoterapéutica
del hospital y realizar una búsqueda de datos de estabilidad durante el almacenamiento …

4CPS-039 Effectiveness of erenumab and galcanezumab in the treatment of migraine

MA Carvajal-Sanchez, MD Najera-Perez… - 2022 - ejhp.bmj.com
Background and importance Migraine is a neurological disorder characterised by episodic
and recurrent seizures. Erenumab and galcanezumab are two monoclonal antibodies (MA) …

5PSQ-207 Analysis of the medicines under additional monitoring authorised in the European Union from 2017 to 2019

P Pacheco-López, CF Zamora, MÁ Carvajal-Sánchez… - 2021 - ejhp.bmj.com
Background and importance The medicines under additional monitoring (MUAMs), identified
with a black inverted triangle (▾), are subject to strict control for 5 years after their …

PHC-009 Drug Dose Adjustment in Renal Failure

AMR Cerdá, P Selvi-Sabater… - European Journal of …, 2013 - ejhp.bmj.com
Background In renal failure, alteration in the pharmacokinetics increases the frequency of
overdoses. Purpose To evaluate pharmaceutical care using a computer programme for drug …

CP-157 Analysis of the expenditure on the treatment of hepatitis C virus in 2015

ID Gorostiza-Frias, P Selvi-Sabater… - 2016 - ejhp.bmj.com
Background With the advent of new treatments for hepatitis C, we have achieved high cure
rates, although this entails a significant increase in drug spending. Purpose To describe and …

[PDF][PDF] Nerna, Nerna!

M Najera Perez - 2017 - digitalcommons.linfield.edu
"Nerna, Nerna!" Page 1 Linfield University DigitalCommons@Linfield 2016-17 Postcards
Postcards from Abroad 2-7-2017 "Nerna, Nerna!" Myrna Najera Perez Linfield College Follow …

4CPS-223 Anticoagulant therapy in chronic complex patients with atrial fibrillation

M Soria-Soto, A Gomez-Gil, M Pascual-Barrriga… - 2019 - ejhp.bmj.com
Background Non-valvular atrial fibrillation (NVAF) is the most common cardiac arrhythmia in
clinical practice. In Spain, the stipulated recommendations to select anticoagulants are: use …

4CPS-099 Nintedanib and pirfenidone in idiopathic pulmonary fibrosis: comparative effectiveness and safety in a third-level hospital

J Ibanez-Caturla, PT Belmonte, LF González… - 2023 - ejhp.bmj.com
Background and Importance Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive
disease characterised by a bad prognosis. The only available pharmacological treatments …